Drugs Made In America Acquisition II Corp Unit
DMIIU
9 hedge funds and large institutions have $14.6M invested in Drugs Made In America Acquisition II Corp Unit in 2026 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
3.95% less ownership
Funds ownership: 6.73% → 2.77% (-4%)
18% less funds holding
Funds holding: 11 → 9 (-2)
100% less capital inflows, than outflows
Capital inflows: $83.3K | Capital outflows: $20.7M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Clear Street
New York
|
+$83.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LMR Partners
London,
United Kingdom
|
-$20.3M |
| 2 |
Rangeley Capital
New Canaan,
Connecticut
|
-$331K |
| 3 |
HRT Financial
New York
|
-$4.72K |
DMIIU Hedge Fund Activity: Q3 2026 in Review
9 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Unit (DMIIU) for Q3 2026, worth a combined $14.6M — down 58% from $35M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DMIIU and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, adding an estimated $83.3K. The largest seller was LMR Partners, exiting entirely with an estimated $20.3M sold.
- 9 institutional investors held Drugs Made In America Acquisition II Corp Unit (DMIIU) as of Q3 2026, down from 11 in Q2 2026.
- Funds reported $14.6M of Drugs Made In America Acquisition II Corp Unit stock for Q3 2026, down 58% quarter-over-quarter.
- 0 funds opened new Drugs Made In America Acquisition II Corp Unit positions in Q3 2026 and 2 closed out, a net change of -2 holders.
- The largest Drugs Made In America Acquisition II Corp Unit buyer in Q3 2026 was Clear Street, an estimated $83.3K added.
- The largest Drugs Made In America Acquisition II Corp Unit seller in Q3 2026 was LMR Partners, an estimated $20.3M sold.
Based on aggregated 13F filings for Q3 2026.